Sale disclosed
Daniel J. Lippis
CVP, TAVR
Common Stock
- Reported value
- $54.17K
- Reported price
- $87.51 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Edwards Lifesciences Corp
Last 30 daysNo qualifying insider buying. Sales: $54.17K by 1 insider.
Showing the first 6 of 20 trades on this page.
CVP, TAVR
Common Stock
SVP, Corporate Controller
Common Stock
CVP, EMEACLA
Common Stock
CVP, TMTT, Surgical & IHFM
Common Stock
CVP, TMTT, Surgical & IHFM
Common Stock
CVP, JAPAC
Common Stock
CVP, TAVR
Common Stock
CVP, JAPAC
Common Stock
CVP, JAPAC
Common Stock
CEO
Common Stock
CVP, TAVR
Common Stock
CVP, TAVR
Common Stock
CEO
Common Stock
SVP, Corporate Controller
Common Stock
CVP,Strategy/Corp Development
Common Stock
CVP, TMTT & Surgical
Common Stock
CVP, TAVR
Common Stock
CVP,Strategy/Corp Development
Common Stock
CVP,Strategy/Corp Development
Common Stock
CEO
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| CVP, TAVR | Common StockSale10b5-1 | 619$87.51 / share | $54.17K | Sep 11Filed Sep 11 · 0d later | SEC filing |
| SVP, Corporate Controller | Common StockSale | 544$91.06 / share | $49.53K | Aug 31Filed Aug 31 · 0d later | SEC filing |
| CVP, EMEACLA | Common StockSale | 2,644$89.98 / share | $237.91K | Aug 28Filed Aug 28 · 0d later | SEC filing |
| CVP, TMTT, Surgical & IHFM | Common StockSale2 trades | 31,800avg $91.02 / share | $2.89M | Aug 26Filed Aug 26 · 0d later | 2 filings
|
| CVP, JAPAC | Common StockSale | 1,240$91.47 / share | $113.42K | Aug 26Filed Aug 26 · 0d later | SEC filing |
| CVP, TAVR | Common StockSale10b5-1 | 619$92.03 / share | $56.97K | Aug 11Filed Aug 11 · 0d later | SEC filing |
| CVP, JAPAC | Common StockSale | 146$86.03 / share | $12.59K | Jul 30Filed Jul 30 · 0d later | SEC filing |
| CVP, JAPAC | Common StockSale | 9,628$85.06 / share | $818.96K | Jul 28Filed Jul 28 · 0d later | SEC filing |
| CEO | Common StockSale | 2,921$83.93 / share | $245.13K | Jul 27Filed Jul 27 · 0d later | SEC filing |
| CVP, TAVR | Common StockSale10b5-1 | 619$91.70 / share | $56.76K | Jul 10Filed Jul 10 · 0d later | SEC filing |
| CVP, TAVR | Common StockSale10b5-1 | 619$91.40 / share | $56.58K | Jun 30Filed Jun 30 · 0d later | SEC filing |
| CEO | Common StockSale10b5-1 | 523$87.92 / share | $45.98K | Jun 17Filed Jun 17 · 0d later | SEC filing |
| SVP, Corporate Controller | Common StockSale | 568$86.08 / share | $48.85K | May 29Filed May 29 · 0d later | SEC filing |
| CVP,Strategy/Corp Development | Common StockSale | 23,145$86.42 / share | $2M | May 27Filed May 27 · 0d later | SEC filing |
| CVP, TMTT & Surgical | Common StockSale | 1,500$84.60 / share | $126.91K | May 22Filed May 22 · 0d later | SEC filing |
| CVP, TAVR | Common StockSale10b5-1 | 620$81.14 / share | $50.31K | May 18Filed May 18 · 0d later | SEC filing |
| CVP,Strategy/Corp Development | Common StockSale2 trades | 17,968avg $81.96 / share | $1.47M | May 15Filed May 18 · 3d later | 2 filings
|
| CEO | Common StockSale10b5-1 | 845$78.40 / share | $66.25K | May 12Filed May 12 · 0d later | SEC filing |
Showing the latest 20 of 30 trades. Show all 30 trades
Edwards Lifesciences Corporation Common Stock · Stock
The filing reports a purchase for the member.
Edwards Lifesciences Corporation Common Stock (EW) · Stock
The filing reports a sale for a joint account.
Josh GottheimerReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.